USA v. Holmes et al
Case Number:
5:18-cr-00258
Court:
Nature of Suit:
Judge:
Firms
-
October 03, 2022
Elizabeth Holmes Gets Hearing On Alleged Gov't Misconduct
A California federal judge who oversaw the criminal fraud trial of ex-Theranos CEO Elizabeth Holmes on Monday ordered an evidentiary hearing to look into "limited, but serious" questions about whether prosecutors engaged in misconduct with respect to a key government witness, delaying her sentencing previously set for Oct. 17.
-
September 21, 2022
Feds Call Holmes' New Trial Bids 'Ploy' To Delay Sentencing
Federal prosecutors opposed former Theranos CEO Elizabeth Holmes' new trial requests Wednesday, filing three back-to-back response briefs in California federal court that argued no new evidence has been discovered since Holmes was convicted of fraud and conspiracy, and calling Holmes' arguments "a ploy to delay her inevitable sentencing."
-
September 14, 2022
Holmes' New Trial Bid Is 'Mt. Everest' Uphill Fight, Attys Say
Convicted former Theranos CEO Elizabeth Holmes faces a "Mount Everest-type" uphill battle for a new criminal fraud trial, white collar experts tell Law360, but recent revelations that a key government witness regrets his testimony may open the door for a post-trial evidentiary hearing and an appeal that could delay her prison sentence.
-
September 08, 2022
Holmes' 3rd New Trial Bid Targets Missing Database Emails
Convicted former Theranos CEO Elizabeth Holmes filed a third request for a new trial late Wednesday, this time arguing that prosecutors unveiled new evidence during co-defendant Ramesh "Sunny" Balwani's criminal trial regarding their efforts to preserve a missing Theranos database and that the new information is grounds for a new trial.
-
September 07, 2022
Elizabeth Holmes Files 2nd New Trial Bid, Citing Balwani Trial
Convicted former Theranos CEO Elizabeth Holmes filed a second request for a new criminal fraud trial Wednesday, arguing that prosecutors dramatically shifted their take on her relationship with her convicted co-conspirator Ramesh "Sunny" Balwani during his recent trial, and the government's "new narrative" warrants a trial do-over for Holmes.
-
September 06, 2022
Holmes Wants New Trial After Key Witness Expresses Regrets
Convicted former Theranos CEO Elizabeth Holmes asked a California federal judge for a new criminal fraud trial Tuesday, arguing that the government's star witness, former Theranos lab director Adam Rosendorff, recently tried to contact Holmes to express regrets about testifying against her, and she deserves a do-over.
-
September 01, 2022
Holmes Acquittal Bid Denied As Attys Hint At New Info
A California federal judge issued a preliminary ruling from the bench Thursday denying ex-Theranos CEO Elizabeth Holmes' request for a post-trial acquittal on charges she defrauded investors with bogus blood-testing technology, while her attorneys told the judge they plan to file a new trial motion based on "newly discovered" information.
-
July 12, 2022
Ex-Theranos CEO Holmes' Sentencing Delayed Until October
Convicted former Theranos CEO Elizabeth Holmes' sentencing for four counts of wire fraud and conspiracy has been delayed three weeks from Sept. 26 to Oct. 17, according to a clerk's notice filed in California federal court Monday.
-
July 08, 2022
4 Takeaways From Ex-Theranos Exec Balwani's Fraud Verdict
Former Theranos executive Ramesh "Sunny" Balwani likely faces a tougher sentence for his recent fraud and conspiracy conviction than his co-conspirator, former Theranos CEO Elizabeth Holmes, due in part to his age and experience, but his defense attorneys have teed up clear issues that are ripe for appeal, according to legal experts.
-
July 07, 2022
Former Theranos Exec Sunny Balwani Convicted Of Fraud
In a dramatic epilogue to the criminal fraud conviction of former Theranos CEO Elizabeth Holmes in January, a California federal jury on Thursday convicted the company's former chief operating officer — and Holmes' onetime boyfriend — Ramesh "Sunny" Balwani of criminal fraud and conspiracy for cheating investors and patients.